All Stories

  1. Percutaneous endoscopic gastrostomy improves survival and nutritional outcomes in patients with head and neck cancer
  2. Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker‐Based Strategy—Authors' Reply
  3. Cost‐Utility Analysis of Biomarker‐Based vs. USG + AFP Strategies for HCC Surveillance in Chronic Hepatitis B
  4. Whole-Genome Sequencing and Antibiotic Resistance Profiling of Helicobacter pylori Isolates from a Tertiary Hospital in Southern Thailand
  5. A nationwide population-based cross-sectional time series study of hospitalized chronic liver disease burden in Thailand from 2017 to 2022
  6. Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions
  7. Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database
  8. Serum sodium level is predictive for kidney injury or hyponatremia after modest-volume paracentesis (<5 L) in Asian patients with cirrhosis: A single-centered retrospective observational study
  9. Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B
  10. Current and new strategies for hepatocellular carcinoma surveillance
  11. Role of Plasma Exchange and Combining Therapies in Dengue-Associated Acute Liver Failure: A Systematic Review of Individual Cases
  12. Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
  13. Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
  14. Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis
  15. Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD
  16. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
  17. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
  18. Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral Helicobacter pylori relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression
  19. Clostridioides difficile Infection in the Elderly: Trend Analysis from 2000 to 2019
  20. Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  21. Efficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study
  22. Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial
  23. Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
  24. Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
  25. Prevalence and virulence factors of Helicobacter pylori isolated from oral cavity of non-disease, gastritis, and gastric cancer patients
  26. Non-Invasive Serum Biomarkers for the Diagnosis of Cirrhosis in Patients with Autoimmune Hepatitis (AIH) and AIH-Primary Biliary Cholangitis Overlap Syndrome (AIH-PBC): Red Cell Distribution Width to Platelet Ratio (RPR) Yielded the Most Promising Result
  27. Health-related quality of life in Thai patients with chronic hepatitis B
  28. Characterization of adhesion, anti-adhesion, co-aggregation, and hydrophobicity of Helicobacter pylori and probiotic strains
  29. Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
  30. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
  31. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US
  32. HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program
  33. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
  34. Massive biliary ascariasis: an unusual cause of acute cholangitis
  35. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
  36. Amoxycillin-Clavulanic Acid-Induced Esophageal Ulcer: An Unusual Cause
  37. Hepatitis B surface antigen, core‐related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation
  38. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
  39. Elephantiasic Pretibial Myxedema: A Rare Manifestation in Graves’ Disease
  40. Phlegmonous Proctitis: A Rare Entity of the Presentation of Proctitis
  41. Acral Hyperpigmentation Resulting from Hydroxyurea Therapy in Primary Myelofibrosis
  42. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial
  43. Efficacy and safety profile of autologous blood Vs talc pleurodesis for MPE